Evidence map›Paper›PMID 39497323›Full record

ArticleBasic & clinical pharmacology & toxicology2025

Population pharmacokinetic modelling of cetirizine concentrations in human breast milk-A contribution from the ConcePTION project.

Erik Melander, Elisabet I Nielsen, Annika Lindqvist, Markus Hovd, Peggy Gandia, Alice Panchaud, Monia Guidi, Pieter Annaert, Pawel Baranczewski, Olav Spigset and 1 more

Abstract read
In one paragraph

Article in Basic & clinical pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Using Relative Infant Dose to Assess Drug Exposure in Breastfed Infants.Basic & clinical pharmacology & toxicology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Erik MelanderDepartment of Pharmacy, Uppsala Drug Optimization and Pharmaceutical Profiling (UDOPP), Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0009-0002-9981-3505
Elisabet I NielsenDepartment of Pharmacy, Clinical Pharmacy research group, Uppsala University, Uppsala, Sweden.
Annika LindqvistDepartment of Pharmacy, Uppsala Drug Optimization and Pharmaceutical Profiling (UDOPP), Uppsala University, Uppsala, Sweden.
Markus HovdSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0002-6077-0934
Peggy GandiaPharmacokinetics and Toxicology laboratory, Toulouse University Hospital, Toulouse, France.
Alice PanchaudInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Monia GuidiCenter for Research and Innovation in Clinical Pharmaceutical Sciences, University Hospital and University of Lausanne, Lausanne, Switzerland.
Pieter AnnaertDepartment of Pharmaceutical and Pharmacological Sciences, Drug Delivery and Disposition, KU Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0003-3525-7351
Pawel BaranczewskiDepartment of Pharmacy, Uppsala Drug Optimization and Pharmaceutical Profiling (UDOPP), Uppsala University, Uppsala, Sweden.
Olav SpigsetDepartment of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Hedvig NordengDepartment of Pharmacy, Pharmacoepidemiology and Drug Safety Research Group, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0001-6361-2918

Funding

Innovative Medicines Initiative 821520
6 · The paper itself

Abstract

Cetirizine is an antihistamine commonly used to treat allergic rhinitis and other allergic conditions. Cetirizine is often prescribed to breastfeeding mothers although there is limited information on infant exposure via breast milk. The aim of this study was to develop a popPK model based on data from a lactation study to predict cetirizine breast milk concentrations and estimate the relative infant dose (RID) in a breastfed infant. A popPK model was developed in NONMEM on data from a human lactation study including 35 women using cetirizine or levocetirizine while breastfeeding. Serial samples of breast milk were collected (n = 205) and the cetirizine concentrations quantified using a validated LC-MS/MS method. A one-compartment model of cetirizine in breast milk was developed and employed to calculate the relative infant dose (RID). Covariates related to the maternal characteristics and breastfeeding patterns were evaluated in the model; only milk sampling pumping duration was found to be a significant covariate, with an increasing pumping duration leading to an increased apparent milk volume of distribution (V

Indexed as

Breast FeedingCetirizineMilk, HumanModels, BiologicalAdultChromatography, LiquidFemaleHistamine H1 Antagonists, Non-SedatingHumansInfantInfant, NewbornLactationTandem Mass SpectrometryYoung AdultCetirizineHistamine H1 Antagonists, Non-Sedatinglevocetirizineantiallergic drugsdrugs during pregnancy and nursinghistaminepharmacokinetic modellingpharmacokinetics

Identifiers

PMID39497323
PMCPMC11655701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.